Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1623 1693 1699
This examiner grants 60% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17772940 | AZAPODOPHYLLOTOXIN DERIVATIVES AND METHODS OF TREATING LYMPHOMA AND KIDNEY CANCER | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 17904907 | COMPOSITION AND METHOD TO PREPARE LONG-ACTING INJECTABLE SUSPENSION CONTAINING MULTIPLE CANCER DRUGS | Non-Final OA | University of Washington |
| 18001655 | THERAPEUTIC TREATMENT USING PROTEIN KINASE C (PKC) INHIBITORS AND CYTOTOXIC AGENTS | Non-Final OA | Cambridge Enterprise Limited |
| 17772872 | METHOD FOR MANUFACTURING REVAUDIOSIDE-D-CONTAINING CRYSTALLIZED PRODUCT, AND REVAUDIOSIDE-D-CONTAINING CRYSTALLIZED PRODUCT | Non-Final OA | SUNTORY HOLDINGS LIMITED |
| 17772848 | METHOD FOR MANUFACTURING REVAUDIOSIDE-D-CONTAINING CRYSTALLIZED PRODUCT, AND REVAUDIOSIDE-D-CONTAINING CRYSTALLIZED PRODUCT | Non-Final OA | SUNTORY HOLDINGS LIMITED |
| 17871121 | METHODS FOR PURIFICATION OF MESSENGER RNA | Final Rejection | Translate Bio, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy